Vermillion vermillion.com


Public lists: Womens Health Startups (468)

Vermillion, formerly Ciphergen Biosystems, is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its prestigious scientific collaborators, has diagnostic programs in oncology, hematology, cardiology and women's health. Vermillion is based in Fremont, California.

Vermillion, formerly Ciphergen Biosystems, is dedicated to the discovery, development and commercialization of novel high-value diagnostic tests that help physicians diagnose, treat and improve outcomes for patients. Vermillion, along with its presti...Show all

Company (IPO / Went public)

Phone: 510-226-2800

Fax:

47350 Fremont Boulevard

Fremont, 94538
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Vermillion $53.4M May 20, 2015
See all 13 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Vermillion Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 23 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Calibrant Biosystems

Gaithersburg, Maryland, United States
Alive / ActiveCalibrant Biosystems is a company that received a SBIR Phase I grant for a project entitled: Micro/Nanofluidic Protein Profiler for Pathogen Detection. Their project will develop a micro/nano fluidic proteomic platform for pathogen detection and identification. The system is based on the use of high-resolution, two-dimensional (2-D) protein separations in disposable microfluidic chips to generate protein expression maps which may be used to identify biomarker patterns unique to specific pathogen...Show allLogin to see details

Proteome Systems

Australia
Alive / ActiveTyrian Diagnostics is a biotechnology company that specialises in the discovery of biomarkers of disease and in diagnostic test development. The company are building a strong intellectual property portfolio to develop a pipeline of diagnostic products and establishing commercial partnerships to maximise market share and revenue generation from these products. One key avenue for commercialisation is the application of biomarkers to the company's point of need test platform, DiagnostIQTM.Login to see details
See all 13 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Predictive biomarkers for ovarian cancer Feb 11, 2016 Dec 19, 2017 Patent
Biomarker for ovarian cancer ctap3-related proteins Mar 18, 2014 Nov 14, 2017 Patent
Predictive markers for ovarian cancer Feb 04, 2014 Mar 01, 2016 Patent
�-2 microglobulin as a biomarker for peripheral artery disease Jan 16, 2013 Apr 29, 2014 Patent
Biomarkers for ovarian cancer Feb 13, 2012 Mar 25, 2014 Patent
See all 32 patents